This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Tersera Therapeutics LLC. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Kalyan Nuguru: Innovator in Pharmaceutical Dosage Forms
Introduction
Kalyan Nuguru is a notable inventor based in Overland Park, Kansas, recognized for his contributions to the field of pharmaceuticals. He holds a patent that focuses on solid dosage forms of a specific compound, showcasing his expertise in drug formulation and development.
Latest Patents
Kalyan Nuguru's patent involves solid pharmaceutical dosage forms comprising (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate, commonly known as telotristat. This patent not only discloses the solid dosage forms but also outlines methods of making them and compositions useful in their manufacture.
Career Highlights
Throughout his career, Kalyan has worked with prominent companies in the pharmaceutical industry, including Tersera Therapeutics LLC and Lexicon Pharmaceuticals, Inc. His experience in these organizations has contributed significantly to his knowledge and expertise in drug development.
Collaborations
Kalyan Nuguru has collaborated with notable professionals in the field, including Jinling Chen and Matthew S Deaver. These collaborations have likely enhanced his research and development efforts in pharmaceutical innovations.
Conclusion
Kalyan Nuguru is a distinguished inventor whose work in solid dosage forms has made a significant impact in the pharmaceutical industry. His patent and collaborations reflect his commitment to advancing drug formulation and improving patient outcomes.